Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
EZ Cap™ Firefly Luciferase mRNA: Bridging RNA Delivery Gaps
2026-06-22
Discover how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure advances mRNA delivery and translation efficiency assays by addressing the key bottleneck of cytosolic RNA release, drawing on new polymer-LNP strategies. Gain practical protocol guidance and unique insights not found in standard molecular biology workflows.
-
Standardized Whole-Blood Stimulation for Immunometabolism An
2026-06-21
The reference study introduces a rigorously standardized protocol for whole-blood stimulation with metabolic modulation, enabling detailed analysis of immune responses under defined metabolic interventions. This advance provides a reproducible foundation for immunometabolism research and facilitates the exploration of metabolic regulation in human immunity.
-
Masitinib (AB1010): Technical Guidance for KIT/PDGFR Inhibit
2026-06-20
Masitinib (AB1010) is a highly selective phenylaminothiazole-type tyrosine kinase inhibitor targeting KIT, PDGFRα, and PDGFRβ. It is optimized for research requiring precise inhibition of these pathways, such as cancer, mastocytosis, and related inflammatory disease studies. This compound should be employed in DMSO-based protocols and is unsuitable for workflows needing water or ethanol solubility, or broad-spectrum kinase activity.
-
Technical Guide: L-Alanyl-L-Glutamine (B8228) in GI Research
2026-06-19
L-Alanyl-L-Glutamine addresses stability and solubility challenges in glutamine supplementation for gastrointestinal and cellular assays. It is suitable for workflows needing enhanced intestinal mucosa protection or antioxidant system support, but should not be used in protocols requiring organic solvent solubility or extended solution storage.
-
Cefepime (BMY-28142): Mechanism, CNS Uses, and Research Para
2026-06-19
Cefepime (BMY-28142) is a broad-spectrum cephalosporin antibiotic with robust penetration of the blood-brain barrier. It is widely used in central nervous system infection models and resistance studies due to its activity against Gram-positive and Gram-negative bacteria. APExBIO supplies a research-grade formulation validated for experimental workflows.
-
TPPU and the sEH–Nrf2 Axis: Redefining Lipid Signaling in Bo
2026-06-18
Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, enables breakthroughs in lipid signaling and bone-inflammation research. This article uniquely focuses on the sEH–Nrf2 axis and practical assay design, with insights not covered in standard protocols.
-
SM-102: Advancing Localized mRNA Delivery for Cancer Therapy
2026-06-18
Explore how SM-102, a key synthetic lipid, is revolutionizing localized mRNA delivery systems for cancer therapy. This in-depth analysis highlights its unique physicochemical properties, practical protocol guidance, and translational significance, setting it apart from existing overviews.
-
Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S
2026-06-17
Recent research identifies moxidectin as a potent synergist with polyene antifungals, opening new avenues for combating resistant Candida albicans infections. This article details experimental workflows, troubleshooting strategies, and the translational value of high-purity moxidectin from APExBIO for advanced antifungal and veterinary antiparasitic applications.
-
Safe DNA Gel Stain: Sensitive, Less Mutagenic Nucleic Acid D
2026-06-17
Safe DNA Gel Stain offers high-sensitivity DNA and RNA gel staining with reduced mutagenicity compared to ethidium bromide. Its compatibility with blue-light excitation enables safer workflows and improved cloning efficiency for molecular biology applications.
-
Difloxacin HCl: Unraveling Mechanisms in Antimicrobial and M
2026-06-16
Explore Difloxacin HCl as a quinolone antimicrobial antibiotic with unique insight into its dual roles in bacterial DNA replication inhibition and multidrug resistance (MDR) reversal. This article offers a mechanistic deep-dive and practical assay guidance not covered in standard reviews.
-
Translating Redox Sensing: 2',7'-Dichlorofluorescein Diaceta
2026-06-16
This thought-leadership article explores the mechanistic and strategic underpinnings of using 2',7'-Dichlorofluorescein diacetate as a robust probe for intracellular ROS detection in translational oncology. Leveraging recent breakthroughs in ROS-responsive nanocarrier design for pancreatic cancer, we outline best practices, competitive context, and visionary applications—demonstrating how APExBIO’s probe empowers researchers to decode tumor microenvironment dynamics and refine therapeutic innovation.
-
Tamsulosin in Urological Research: Precision Mechanisms & Pr
2026-06-15
Explore the advanced mechanism and translational significance of Tamsulosin, a selective α₁A-adrenergic receptor antagonist, in urological disease research. This article uniquely bridges structural pharmacology with protocol optimization, setting a new benchmark for research applications.
-
Doxorubicin Hydrochloride in Cancer and Cardiotoxicity Model
2026-06-15
Doxorubicin hydrochloride (Adriamycin HCl) is central to cancer chemotherapy research, enabling both cytotoxicity assays and in vivo cardiotoxicity modeling. This article delivers workflow-centric guidance, practical troubleshooting, and insights from the latest mechanistic studies—including antioxidant rescue strategies—to optimize your experimental outcomes.
-
DAMGO: Precision µ-Opioid Receptor Agonist for Pain Models
2026-06-14
DAMGO empowers researchers to dissect central opioid receptor signaling with unrivaled selectivity, enabling advanced investigation of tolerance and hypersensitivity mechanisms in chronic pain models. The latest evidence highlights DAMGO’s pivotal role in clarifying central versus peripheral pathways, making it indispensable for reproducible opioid pharmacology studies.
-
JNK-IN-7 in Decoding JNK-Mediated Apoptosis and Immune Modul
2026-06-13
Discover how JNK-IN-7, a selective JNK inhibitor, empowers advanced research into apoptosis and innate immune signaling. This article uniquely dissects its mechanistic advantages and assay design implications, bridging molecular insight with practical application.
8594 records 11/573 page Previous Next First page 上5页 1112131415 下5页 Last page